Long3759.HKJun 2026
Pharmaron Beijing Co., Ltd.
Pharmaron is positioned to benefit from China's growing role in global biopharma innovation. Its integrated discovery, development and manufacturing platform lets it participate…
3759.HK
Which hedge funds are long 3759.HK?
3 published ideas on Pharmaron Beijing Co., Ltd. across 2 funds — 3 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Pharmaron Beijing Co., Ltd.: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Funds with a position view
Long theses
Long3759.HKJun 2026
Pharmaron Beijing Co., Ltd.
Ariel expects Pharmaron to benefit from China's growing role in global biopharma innovation and the increasing externalization of drug discovery and development by large…
Long3759.HKJun 2026
Pharmaron Beijing Co., Ltd.
Pharmaron is positioned to benefit from China's growing role in global biopharma innovation. Its integrated discovery, development and manufacturing platform lets it participate…